16 results

• Side Effects of Aranesp, Procrit and Epogen Lead to New FDA Restrictions

  February 17, 2010

  Staff Writers

  Concerns over the increased risk of heart attacks, blood clots, tumors and death from side effects of Aranesp, Procrit and...

• Aranesp, Epogen and Procrit Health Risks to be Reviewed Further by FDA

  January 8, 2010

  AboutLawsuits

  The FDA indicates that it will further examine the side effects of anemia drugs, including Aranesp, Epogen and Procrit, due...

• Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study

  November 11, 2009

  AboutLawsuits

  According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but...

• Aranesp Increases Risk of Stroke for Some Patients: Study

  November 2, 2009

  AboutLawsuits

  New research suggests that side effects of Aranesp, an anemia drug, could increase the risk of stroke in some patients.

• FDA Reviewing Epogen and Procrit Side Effects After Study Identifies Risk of Death

  September 29, 2008

  AboutLawsuits

  The FDA has issued an “Early Communication” about their ongoing safety review of a potential increased risk of death associated...

• Epogen and Procrit Side Effects Linked to Death for Stroke Patients

  September 19, 2008

  AboutLawsuits

  Preliminary data from a study funded by Johnson & Johnson’s Ortho Biotech unit found that individuals who were given Procrit...